Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection

Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection

Tuberculosis (TB) remains a main public health concern and 10.4 million new cases occurred in 2015 around the world. BCG is the only approved vaccine against TB, but has variable efficacy and new vaccines are needed. We developed two new mTB vaccine candidates based on the recombinant fusion protein...

Full description

Saved in:
Bibliographic Details
Main Authors: Bruno de Paula Oliveira Santos (Author), Monalisa Martins Trentini (Author), Renato Beilner Machado (Author), Mara Rúbia Nunes Celes (Author), André Kipnis (Author), Nikolai Petrovsky (Author), Ana Paula Junqueira-Kipnis (Author)
Format: Book
Published: Taylor & Francis Group, 2017-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items